TokenPost·
Praxis Precision Medicines Posts Q3 GAAP Net Loss of $3.23 Per Share
Cash, cash equivalents and marketable securities totaled $1.3 billion on Sept. 30, compared with $926.1 million on Dec. 31, 2025.
More news
- The DefiantCoinbase, Five Firms Back CFTC in Stock Perps Lawsuit
- TokenPostAura Biosciences Posts $0.29 GAAP Loss Per Share for Q3 2026
- crypto.newsThe Bitcoin inheritance gap between a will and a wallet
- TokenPostADC Therapeutics Revenue Climbs 32.9% to $21 Million in Third Quarter
- TokenPostKKR Beats Third-Quarter Earnings Expectations as Fee-Related Earnings Grow
- TokenPostBank of America Sees Letterboxd as a Fit for The New York Times